Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Next Step For FDA's 'Case For Quality'? 8 New Guidance Docs

This article was originally published in The Gray Sheet

Executive Summary

Device manufacturers and FDA investigators reported generally positive experiences with FDA’s "critical-to-quality" inspection pilot, but the agency has decided to shift the focus to producing eight new guidance documents to better suit the project’s mission.

Advertisement

Related Content

At The Intersection Of Quality And Metrics: What's Ahead In FDA’s Effort To More Objectively Measure Quality

Topics

Advertisement
UsernamePublicRestriction

Register

MT034364

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel